EA200000040A1 - Способ лечения диабета тиазолидиндионом и ингибитором альфа-глюкозидазы - Google Patents

Способ лечения диабета тиазолидиндионом и ингибитором альфа-глюкозидазы

Info

Publication number
EA200000040A1
EA200000040A1 EA200000040A EA200000040A EA200000040A1 EA 200000040 A1 EA200000040 A1 EA 200000040A1 EA 200000040 A EA200000040 A EA 200000040A EA 200000040 A EA200000040 A EA 200000040A EA 200000040 A1 EA200000040 A1 EA 200000040A1
Authority
EA
Eurasian Patent Office
Prior art keywords
thiazolidindion
alpha
treating diabetes
glucosidase inhibitor
diabetes mellitus
Prior art date
Application number
EA200000040A
Other languages
English (en)
Russian (ru)
Inventor
Стефен Элистэр Смит
Original Assignee
Смитклайн Бичам Плс
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9712865.6A external-priority patent/GB9712865D0/en
Priority claimed from GBGB9806708.5A external-priority patent/GB9806708D0/en
Application filed by Смитклайн Бичам Плс filed Critical Смитклайн Бичам Плс
Publication of EA200000040A1 publication Critical patent/EA200000040A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Plural Heterocyclic Compounds (AREA)
EA200000040A 1997-06-18 1998-06-15 Способ лечения диабета тиазолидиндионом и ингибитором альфа-глюкозидазы EA200000040A1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9712865.6A GB9712865D0 (en) 1997-06-18 1997-06-18 Novel method of treatment
GBGB9806708.5A GB9806708D0 (en) 1998-03-27 1998-03-27 Novel method
PCT/EP1998/003691 WO1998057635A1 (en) 1997-06-18 1998-06-15 Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor

Publications (1)

Publication Number Publication Date
EA200000040A1 true EA200000040A1 (ru) 2000-08-28

Family

ID=26311746

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200000040A EA200000040A1 (ru) 1997-06-18 1998-06-15 Способ лечения диабета тиазолидиндионом и ингибитором альфа-глюкозидазы

Country Status (24)

Country Link
EP (1) EP0975343A1 (xx)
JP (1) JP2001523271A (xx)
KR (1) KR20010013845A (xx)
CN (1) CN1274282A (xx)
AP (1) AP9901720A0 (xx)
AR (2) AR013352A1 (xx)
AU (1) AU8799998A (xx)
BG (1) BG103966A (xx)
BR (1) BR9810186A (xx)
CA (1) CA2294134A1 (xx)
CO (1) CO4940453A1 (xx)
DZ (1) DZ2519A1 (xx)
EA (1) EA200000040A1 (xx)
IL (1) IL133138A0 (xx)
MA (1) MA26510A1 (xx)
NO (1) NO996270D0 (xx)
NZ (1) NZ501345A (xx)
OA (1) OA11631A (xx)
PE (1) PE89199A1 (xx)
PL (1) PL337577A1 (xx)
SK (1) SK179499A3 (xx)
TR (1) TR199903072T2 (xx)
UY (1) UY25051A1 (xx)
WO (1) WO1998057635A1 (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100744359B1 (ko) 1999-04-23 2007-07-30 스미스클라인비이참피이엘시이 티아졸리딘디온 유도체 및 항당뇨병제로서 그의 용도
DE60231295D1 (de) 2001-04-04 2009-04-09 Ortho Mcneil Janssen Pharm R und ppar modulatoren
EP1392326B1 (en) 2001-04-04 2009-09-09 Ortho-McNeil-Janssen Pharmaceuticals, Inc. Combination therapy comprising glucose reabsorption inhibitors and retinoid-x receptor modulators
FR2832930A1 (fr) * 2001-12-03 2003-06-06 Lipha Composition pharmaceutique comprenant un inhibiteur d'alpha-glucosidase et un derive de thiazolidinedione et son utilisation pour la preparation de medicaments destines a traiter le diabete
JP2004067575A (ja) * 2002-08-06 2004-03-04 Yaizu Suisankagaku Industry Co Ltd 糖尿病治療薬効果促進剤
CN101121004B (zh) * 2006-08-08 2010-07-21 鲁南制药集团股份有限公司 含有胰岛素增敏剂和米格列醇的药物组合物
CN101584705B (zh) * 2008-05-24 2010-10-27 鲁南制药集团股份有限公司 一种治疗糖尿病及其并发症的药物组合物
CN101584688B (zh) * 2008-05-24 2010-11-10 鲁南制药集团股份有限公司 一种治疗糖尿病及其并发症的药物组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993003724A1 (en) * 1991-08-26 1993-03-04 The Upjohn Company Pharmaceutical composition containing 3-guanidinopropionic acid and pioglitazone glibenclamide or glimepiride
US5917052A (en) * 1994-09-28 1999-06-29 Shaman Pharmaceuticals, Inc. Hypoglycemic agent from cryptolepis
TW438587B (en) * 1995-06-20 2001-06-07 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes

Also Published As

Publication number Publication date
IL133138A0 (en) 2001-03-19
CO4940453A1 (es) 2000-07-24
AP9901720A0 (en) 1999-12-31
TR199903072T2 (xx) 2000-07-21
SK179499A3 (en) 2000-11-07
BG103966A (bg) 2000-07-31
WO1998057635A1 (en) 1998-12-23
AR013352A1 (es) 2000-12-27
OA11631A (en) 2004-11-22
EP0975343A1 (en) 2000-02-02
DZ2519A1 (fr) 2003-02-01
JP2001523271A (ja) 2001-11-20
AU8799998A (en) 1999-01-04
AR014881A1 (es) 2001-04-11
BR9810186A (pt) 2000-08-08
PE89199A1 (es) 1999-10-23
UY25051A1 (es) 2000-09-29
MA26510A1 (fr) 2004-12-20
CN1274282A (zh) 2000-11-22
PL337577A1 (en) 2000-08-28
CA2294134A1 (en) 1998-12-23
NO996270L (no) 1999-12-17
NO996270D0 (no) 1999-12-17
NZ501345A (en) 2001-10-26
KR20010013845A (ko) 2001-02-26

Similar Documents

Publication Publication Date Title
EA199800316A1 (ru) СЕЛЕКТИВНЫЕ β-АДРЕНЕРГИЧЕСКИЕ АГОНИСТЫ
AR038437A1 (es) Tintura permanente del cabello en dos pasos
DE69625157T2 (de) Behandlung des typ ii-deabetes mellitus mit amylinagonisten
SV1998000010A (es) Combinaciones para diabetes de sulfonilurea-glitazona.
TR200100773T2 (tr) Bir aP2 önleyicisinin ve kombinasyonunun kullanıldığı diyabet tedavi yöntemi
EA200300036A1 (ru) Комбинации ингибиторов дипептидилпептидазы iv и других антидиабетических агентов для лечения сахарного диабета
DE69117163D1 (de) Stickoxidreduktion mittels eines harnstoffhydrolysats
DK0869796T3 (da) Glibenclamid-metformin-kombination til behandling af diabetes mellitus type II
FI900649A0 (fi) Menetelmä lignoselluloosamateriaalin valkaisemiseksi happi- ja entsyymikäsittelyllä
NO975693D0 (no) Rekombinant heksoseoksidase, fremgangsmåte for fremstilling av dette og anvendelse av et slikt enzym
FI971420A (fi) Menetelmä diabetes mellituksen hoitamiseksi KGF:ää käyttämällä
TR200000755T2 (tr) Karşıt olma-karşı gelme bozukluğunun tedavisi.
NO863342D0 (no) Sperrepolarisator og polarisasjonsmetode, spesielt for lys ledet av en optisk fiber.
EA200000040A1 (ru) Способ лечения диабета тиазолидиндионом и ингибитором альфа-глюкозидазы
DE69733244D1 (de) Verbrennungsverfahren mit geringen akustischen Tönen
NO975830L (no) Fremgangsmåte for å öke hvitlutpenetreringen inn i treflis
DE69535239D1 (de) Verbrennung von organischen Abfällen
EA200000140A1 (ru) Способ лечения диабета тиазолидиндионом, средством, усиливающим секрецию инсулина, и ингибитором альфа-глюкозидазы
FI945695A (fi) Menetelmä sellukuitujen valmistamiseksi, joiden fibrilloitumistaipumus on vähentynyt
PT1067966E (pt) Composicao oftalmica compreendendo um bloqueador beta
DE68915968T2 (de) Abgasbehandlungsmethode.
ES2176947T3 (es) Compresion de audio.
FI950014A0 (fi) Uusi sellobioosioksidaasi, entsymaattinen aine ja menetelmä paperimassan käsittelemiseksi
EA200000039A1 (ru) Лечение диабета тиазолидиндионом и сульфонилмочевиной
AR038739A1 (es) Un metodo para lograr un cambio permanente de color de cabello deseado utilizando intermediarios de tintura en agua a ph alcalino que contiene compuestos de amonio cuaternario